News from the Eugendorf Laboratory Novogenia: The laboratory, which was in the headlines in the past few months due to gargle tests not being evaluated and poor working conditions, is now listed on the stock exchange. For the time being, the shares are only available to selected people. That should change in the future.
It should actually have been a successful winter for the Novogenia laboratory. In autumn, the company was awarded the contract by the federal government to carry out the nationwide PCR gargle tests for Salzburg. Then things went downhill for the lab. At first the test kits were scarce, then the registration page didn’t work. The evaluation also took far too long, in some cases the results were missing entirely (the “Krone” reported). According to a spokesman for the company, the test system is now working properly again. The company also collected negative headlines – as reported – around the working conditions in the laboratory and the establishment of a works council. The sale of shares had been planned for a long time. Nonetheless, the laboratory is now about to go public. The owner Daniel Wallersdorfer carried out a so-called “silent listing” on the Munich stock exchange for his company. According to a spokesman, this was a step that was planned for the longer term and had nothing to do with the current situation. For the time being, the shares are only available to selected people, and there should be a public offer in January.
source site-12